跳至主要内容
临床试验/NCT02717273
NCT02717273已完成3 期

A Randomized, Prospective Study of Surgical Site Infections in Liver Transplant Patients Receiving Three Days of Peri-operative Antibiotic Prophylaxis Versus Intra-operative Antibiotics Only

University of Virginia0 个研究点目标入组 102 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
102
主要终点
Number of Subjects With Development of Surgical Site Infections

研究概览

简要总结

This study will be to prospectively determine differences in Surgical Site Infection (SSI) if a prolonged course of post-operative antibiotics are used following liver transplantation.

详细描述

This study will be to prospectively determine differences in SSI if a prolonged course of post-operative antibiotics are used following liver transplantation. All adult patients, admitted to the University of Virginia (UVA) Medical Center for first-time liver transplantation will be randomized to the standard of care of peri-operative antibiotics or extended course of three total days.

Patients will be evaluated primarily for the presence of post-operative surgical site infections but also for fever, elevated white blood counts, secondary infections (urinary tract, pneumonia, and blood stream), length of hospital stay, graft loss, and mortality for 30 days after liver transplant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients ≥ 18 years of age.
  • Eligible for liver transplantation by UVA standard protocol.
  • First-time transplantation.
  • No active infections - requiring antibiotics - excluding antifungals.

排除标准

  • All patients < 18 years of age.
  • Previous liver transplantation.
  • Active infections - requiring antibiotics.
  • Allergy to all standard peri-operative antibiotics (piperacillin/tazobactam or UVA standard alternatives for Penicillin allergic patients: ciprofloxacin and vancomycin).

研究组 & 干预措施

standard peri-operative antibiotics

Active Comparator

The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.

干预措施: standard (Drug)

standard peri-operative antibiotics

Active Comparator

The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.

干预措施: liver transplant (Other)

extended three-day course of antibiotics

Experimental

For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.

This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.

干预措施: extended (Drug)

extended three-day course of antibiotics

Experimental

For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.

This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.

干预措施: liver transplant (Other)

结局指标

主要结局

Number of Subjects With Development of Surgical Site Infections

时间窗: within 30 days from surgery

development of surgical site infection, including superficial and deep incisional and organ space surgical site infections

次要结局

  • Number of Subjects With Mortality(within 30 days from surgery)
  • Number of Subjects With Post-operative Fever(24 hours from surgery)
  • Number of Subjects With Elevated White Blood Count (WBC)(24 hours from surgery)
  • Length of Hospital Stay(within 30 days from surgery)
  • Number of Subjects With Nosocomial Infection(within 30 days from surgery)
  • Number of Subjects With Graft Loss(within 30 days from surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Sawyer, MD

Profesor of Surgery

University of Virginia

相似试验